Please login to the form below
cholera
This page shows the latest cholera news and features for those working in and with pharma, biotech and healthcare.
WHO launches funding appeal for greater Horn of Africa prompted by food crisis
WHO has reported outbreaks of measles in six of the seven countries, against a background of low vaccination coverage, and countries fighting both cholera and meningitis outbreaks, as hygiene conditions worsen
Latest news
-
Positive data for Lyme disease booster vaccine
cholera. 30th September 2021.
-
UK to launch world-first COVID-19 human challenge study in the ‘next few weeks’
Human challenge studies have been used previously to support the development of treatments for a range of disease, including malaria, typhoid, cholera, norovirus and influenza.
-
UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
In the past, this type of trial has been used to investigate a range of diseases, including influenza, malaria, typhoid, dengue fever and cholera.
-
Givlaari, Rybelsus lead crowded CHMP recommendations
The CHMP also recommended PaxVax’s cholera vaccine Vaxchora for prophylaxis against choleam and Eli Lilly’s new fast-acting mealtime insulin Liumjev, to improve glycemic control in diabetes in adults.
-
The power of pharma businesses to drive social change
Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases such as Chagas, cholera, dengue fever and schistosomiasis.
More from news
Approximately 1 fully matching, plus 13 partially matching documents found.
Latest from PMHub
-
Love in the Time of Coronavirus
Recommended reading: Love in the Time of Cholera by Gabriel Garcia Marquez, a story about how love can survive a lifetime of separation, including a cholera epidemic. ... The cholera epidemic of 1854 led the physician John Snow to conclude that the
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- Eli Lilly to make bebtelovimab commercially available to US states from August
- ONS records a continued fall in UK COVID-19 infections
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- Engaging KOLs and Gaining Insights in Pharma's New Normal
- That ‘don’t’ impress me much
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- Novartis’ Pluvicto receives MHRA marketing authorisation to treat advanced prostate cancer
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- ONS data reveals significant decrease in COVID-19 antibodies
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
- How the Royal Society’s EiR programme can help to drive UK innovation
- ...
